Introduction to oncology clinical development from a quantitative modelling perspective
Dr Fabio Rigat, Oncology Biometrics GI Strategy Head, Executive Director, AstraZeneca, will hold a seminar entitled Introduction to oncology clinical development from a quantitative modeling perspective.
When
Wednesday 7 December at 12:00 in room MS1 of the DICAr (on the ground floor).
Share on: